Innovare Labs - Crunchbase Company Profile & Funding

Q: Where is Innovare Labs's headquarters?

Innovare Labs is located in Hyderabad, Telangana, India.

Overview

Innovare Labs

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Innovare Labs

CB Rank

1511138

Innovare Labs manufactures pharmaceuticals for the cardiovascular, API, and drug intermediate markets.

Founded

obfuscation

Private

Hyderabad, Telangana, India

101-250

www.innovarelabs.com

Health Care

Manufacturing

Pharmaceutical

Key People

Sunil Kumar: Chief Executive Officer

Details

Legal Name

Innovare Labs Private Limited

Operating Status

Active

Company Type

For Profit

About the Company

Innovare Labs is a pharmaceutical manufacturing company that provides cardiovascular, APIs, and drug intermediates. Their APIs are used in various therapeutic segments such as cardiovasculars, antihypertensives, pain management, epileptics, neurologic disorders, and antibiotics.

Phone Number

+91 093910 43710

Contact Email

info@innovarelabs.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Active Pharmaceutical Ingredients (APIs)

Manufacture of APIs for cardiovascular, CNS, anti-bacterial, and anti-diabetic markets according to ICH/USP and customer specifications under cGMP guidelines.

Drug Intermediates

Production of drug intermediates for cardiovascular, CNS, anti-bacterial, and anti-diabetic drugs as per ICH/USP and customer specifications under cGMP guidelines.